Associations between treatment satisfaction, medication beliefs, and adherence to disease modifying therapies in patients with multiple sclerosis

被引：0
|
作者：
Thach, A. V. [1 ]
Brown, C. M. [1 ]
Herrera, V. [2 ]
Sasane, R. [2 ]
Barner, J. C. [1 ]
Ford, K. C. [1 ]
Lawson, K. A. [1 ]
机构：
[1] Univ Texas Austin, Austin, TX 78712 USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1550
引用
收藏
页码：809 / 809
页数：1
相关论文
共 50 条
  • [1] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
  • [2] TREATMENT SATISFACTION WITH DISEASE MODIFYING THERAPIES IN MULTIPLE SCLEROSIS: A SYSTEMATIC REVIEW OF STUDIES USING THE TREATMENT SATISFACTION QUESTIONNAIRE FOR MEDICATION (TSQM)
    Ting, J.
    Liu, Y.
    Petrillo, J.
    Giannattasio, G.
    Sabatella, G.
    VALUE IN HEALTH, 2015, 18 (07) : A760 - A760
  • [3] Adherence to Disease-Modifying Therapies for Multiple Sclerosis
    Higuera, Lucas
    Carlin, Caroline S.
    Anderson, Sarah
    Journal of Managed Care & Specialty Pharmacy, 2016, 22 (12): : 1394 - 1401
  • [4] Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: utility of the health beliefs model
    Turner, A. P.
    Kivlahan, D. R.
    Sloan, A. P.
    Haselkorn, J. K.
    MULTIPLE SCLEROSIS, 2007, 13 (09): : 1146 - 1152
  • [5] Association between multiple sclerosis disease severity and adherence to disease-modifying therapies
    Burkhard, Adam
    Toliver, Joshua
    Rascati, Karen
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (07): : 915 - 923
  • [6] Adherence to disease-modifying therapies and attitudes regarding disease in patients with multiple sclerosis
    Ozura, Ana
    Kovac, Lea
    Sega, Sasa
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S6 - S11
  • [7] REAL-WORLD OUTCOMES AND MEDICATION ADHERENCE TO DISEASE MODIFYING THERAPIES (DMTS) AMONG PATIENTS WITH MULTIPLE SCLEROSIS (MS)
    Grassi, D. M.
    Graham, J.
    Ye, X.
    Maeng, D.
    Frusciante, K.
    Nathanson, D. C.
    Burton, M.
    Wright, E.
    Gomes, J.
    Bao, Y.
    VALUE IN HEALTH, 2018, 21 : S203 - S203
  • [8] COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
    Anthony T. Reder
    Diego Centonze
    Maria L. Naylor
    Anjali Nagpal
    Rajani Rajbhandari
    Arman Altincatal
    Michelle Kim
    Aaron Berdofe
    Maha Radhakrishnan
    Eunice Jung
    Alfred W. Sandrock
    Karen Smirnakis
    Catrinel Popescu
    Carl de Moor
    CNS Drugs, 2021, 35 : 317 - 330
  • [9] COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
    Reder, Anthony T.
    Centonze, Diego
    Naylor, Maria L.
    Nagpal, Anjali
    Rajbhandari, Rajani
    Altincatal, Arman
    Kim, Michelle
    Berdofe, Aaron
    Radhakrishnan, Maha
    Jung, Eunice
    Sandrock, Alfred W.
    Smirnakis, Karen
    Popescu, Catrinel
    de Moor, Carl
    CNS DRUGS, 2021, 35 (03) : 317 - 330
  • [10] Associations between treatment satisfaction, medication beliefs, and adherence to dmt in ms patients: saudi tertiary care center experience
    Alarieh, R.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 261 - 261
12345